Investing.com - Vera Therapeutics (NASDAQ: VERA) reported second quarter EPS of $-0.46, $0.19 better than the analyst estimate of $-0.65. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Vera Therapeutics's stock price closed at $18.49. It is up 144.25% in the last 3 months and up 1.65% in the last 12 months.
Vera Therapeutics saw positive EPS revisions and negative EPS revisions in the last 90 days. See Vera Therapeutics's stock price’s past reactions to earnings here.
According to InvestingPro, Vera Therapeutics's Financial Health score is "fair performance".
Check out Vera Therapeutics's recent earnings performance, and Vera Therapeutics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar